CARBACHOL

CARBACHOL was reported 173 times

CARBACHOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 31 0.4429
1 PRODUCT ADMINISTRATION ISSUE 17 0.0813
2 IRIS HAEMORRHAGE 3 0.0588
3 ANTERIOR CHAMBER PIGMENTATION 1 0.0500
4 ANTERIOR CHAMBER FIBRIN 5 0.0388
5 PUPILLARY BLOCK 1 0.0312
6 CONJUNCTIVAL BLEB 1 0.0185
7 MITRAL VALVE STENOSIS 11 0.0164
8 CORNEAL ENDOTHELIAL CELL LOSS 1 0.0147
9 HEART SOUNDS ABNORMAL 11 0.0146
10 CORNEAL STRIAE 1 0.0141
11 POSTERIOR CAPSULE RUPTURE 1 0.0127
12 PUPILLARY DEFORMITY 1 0.0125
13 TOXIC ANTERIOR SEGMENT SYNDROME 13 0.0119
14 PULMONARY PAIN 31 0.0106
15 ANTERIOR CHAMBER DISORDER 2 0.0087
16 BILIRUBIN URINE PRESENT 1 0.0084
17 CATARACT OPERATION COMPLICATION 4 0.0079
18 HAEMORRHAGIC VASCULITIS 1 0.0076
19 GLARE 3 0.0058
20 FLAT ANTERIOR CHAMBER OF EYE 1 0.0056
21 IRIS ATROPHY 1 0.0048
22 SENSE OF OPPRESSION 5 0.0042
23 CORNEAL DEGENERATION 1 0.0041
24 ENDOPHTHALMITIS 24 0.0040
25 IRIS ADHESIONS 2 0.0039
26 NASAL NEOPLASM 1 0.0037
27 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
28 CHEST X-RAY ABNORMAL 11 0.0036
29 EYE REDNESS 1 0.0036
30 BILE DUCT STONE 11 0.0035
31 RETINAL VASCULITIS 4 0.0034
32 CORNEAL OEDEMA 7 0.0031
33 RETINAL VASCULAR OCCLUSION 2 0.0027
34 HALO VISION 3 0.0027
35 LEFT VENTRICULAR HYPERTROPHY 11 0.0026
36 PROCEDURAL HEADACHE 1 0.0024
37 NON-INFECTIOUS ENDOPHTHALMITIS 2 0.0024
38 CORNEAL OPACITY 3 0.0022
39 FOREIGN BODY IN EYE 2 0.0021
40 OBESITY 31 0.0019
41 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1 0.0018
42 CHOLANGITIS 11 0.0018
43 NAIL INJURY 1 0.0018
44 VITRECTOMY 1 0.0017
45 BLOOD VISCOSITY INCREASED 1 0.0017
46 CYSTOID MACULAR OEDEMA 3 0.0016
47 SURGICAL PROCEDURE REPEATED 1 0.0015
48 EYE ROLLING 1 0.0014
49 ANTERIOR CHAMBER CELL 1 0.0014
50 KNEE ARTHROPLASTY 28 0.0013
51 CARBOHYDRATE ANTIGEN 15-3 INCREASED 1 0.0013
52 PROCEDURAL NAUSEA 1 0.0012
53 HYPOPYON 1 0.0012
54 MEAN PLATELET VOLUME DECREASED 1 0.0012
55 ENDOCRINE OPHTHALMOPATHY 1 0.0012
56 EYE COLOUR CHANGE 1 0.0010
57 CONJUNCTIVAL OEDEMA 1 0.0010
58 EYE INFLAMMATION 9 0.0009
59 HAEMORRHAGIC DISORDER 1 0.0009
60 CARDIOMEGALY 11 0.0009
61 BRONCHOSPASM 11 0.0008
62 HYPERTHYROIDISM 11 0.0008
63 CORNEAL ABRASION 1 0.0007
64 LOWER RESPIRATORY TRACT INFECTION 32 0.0007
65 KERATITIS 2 0.0007
66 PRODUCT DEPOSIT 1 0.0006
67 BLOOD TEST ABNORMAL 9 0.0006
68 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
69 POST PROCEDURAL COMPLICATION 11 0.0006
70 TERMINAL INSOMNIA 1 0.0006
71 ARTHROPATHY 31 0.0006
72 SPUTUM DISCOLOURED 5 0.0005
73 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
74 JOINT CREPITATION 1 0.0005
75 MIOSIS 4 0.0005
76 PRODUCT ADMINISTRATION ERROR 10 0.0005
77 VISUAL ACUITY REDUCED 16 0.0005
78 FULL BLOOD COUNT ABNORMAL 5 0.0005
79 OPTIC NEUROPATHY 1 0.0005
80 CORNEAL DISORDER 1 0.0005
81 WRONG DOSE 1 0.0004
82 NOCTURIA 5 0.0004
83 EYE OEDEMA 1 0.0004
84 MEAN CELL VOLUME INCREASED 1 0.0004
85 DRUG ABUSE 32 0.0004
86 INTENTIONAL PRODUCT MISUSE 31 0.0004
87 NECK MASS 1 0.0004
88 CATARACT OPERATION 2 0.0003
89 MEDICATION ERROR 18 0.0003
90 LYMPHOCYTE COUNT INCREASED 1 0.0003
91 DEAFNESS NEUROSENSORY 1 0.0003
92 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 5 0.0003
93 WOUND COMPLICATION 1 0.0003
94 ERYTHEMA NODOSUM 1 0.0003
95 TYPE I HYPERSENSITIVITY 1 0.0003
96 EYE PRURITUS 9 0.0003
97 EPIGASTRIC DISCOMFORT 1 0.0003
98 SKIN ODOUR ABNORMAL 1 0.0003
99 OCULAR HYPERAEMIA 12 0.0003
100 PRODUCTIVE COUGH 12 0.0003
101 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
102 MYDRIASIS 3 0.0002
103 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 11 0.0002
104 ABDOMINAL ABSCESS 1 0.0002
105 PHYSICAL DISABILITY 1 0.0002
106 VITREOUS FLOATERS 2 0.0002
107 NASAL POLYPS 1 0.0002
108 ABDOMINAL DISCOMFORT 33 0.0002
109 AMMONIA INCREASED 1 0.0002
110 VARICOSE VEIN 1 0.0002
111 APLASTIC ANAEMIA 1 0.0002
112 DRUG DEPENDENCE 30 0.0002
113 WHEEZING 11 0.0002
114 PRODUCT RESIDUE PRESENT 1 0.0002
115 ILL-DEFINED DISORDER 11 0.0002
116 MACULAR OEDEMA 1 0.0002
117 HEART RATE DECREASED 6 0.0002
118 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
119 INTRAOCULAR PRESSURE INCREASED 2 0.0002
120 CHRONIC KIDNEY DISEASE 11 0.0001
121 OVERDOSE 30 0.0001
122 TONGUE DISORDER 1 0.0001
123 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
124 CARDIAC FAILURE 11 0.0001
125 SLEEP DISORDER 9 0.0001
126 POST PROCEDURAL INFECTION 1 0.0001
127 ASTHMA 13 0.0001
128 ORTHOSTATIC HYPOTENSION 2 0.0001
129 ATRIAL FIBRILLATION 11 0.0001
130 PRODUCT DOSE OMISSION ISSUE 32 0.0001
131 RETINAL DETACHMENT 1 0.0001
132 GLAUCOMA 2 0.0001
133 HAEMATOCRIT DECREASED 2 0.0001
134 OEDEMA PERIPHERAL 12 0.0001
135 NEUTROPHIL COUNT INCREASED 1 0.0001
136 TEMPERATURE INTOLERANCE 1 0.0001
137 BREAST PAIN 1 0.0001
138 BREAST CANCER METASTATIC 1 0.0001
139 EYE INFECTION 1 0.0001
140 ADRENAL INSUFFICIENCY 1 0.0001
141 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
142 SARS-COV-2 TEST POSITIVE 1 0.0001
143 HAIR TEXTURE ABNORMAL 1 0.0001
144 DRUG EFFECT DECREASED 4 0.0001
145 COORDINATION ABNORMAL 1 0.0001
146 RASH 31 0.0001
147 BLINDNESS UNILATERAL 1 0.0001
148 NASOPHARYNGITIS 13 0.0001
149 IMPAIRED QUALITY OF LIFE 1 0.0001
150 HOT FLUSH 5 0.0001
151 RESPIRATORY TRACT CONGESTION 1 0.0001
152 INFLUENZA 7 0.0001
153 BLOOD UREA INCREASED 1 0.0001
154 FACE OEDEMA 1 0.0001
155 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
156 ORAL HERPES 1 0.0001
157 EATING DISORDER 1 0.0000
158 GLOSSODYNIA 1 0.0000
159 OFF LABEL USE 35 0.0000
160 HALLUCINATION 3 0.0000
161 INFLAMMATION 2 0.0000
162 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
163 DIPLOPIA 1 0.0000
164 GASTRITIS 1 0.0000
165 PNEUMONIA 12 0.0000
166 EYE PAIN 2 0.0000
167 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
168 RED BLOOD CELL COUNT DECREASED 1 0.0000
169 RESPIRATORY DISORDER 1 0.0000
170 ASTHENIA 12 0.0000
171 HYPOTHYROIDISM 1 0.0000
172 HIP FRACTURE 1 0.0000
173 CHOLELITHIASIS 1 0.0000
174 BLOOD PRESSURE DECREASED 2 0.0000
175 DYSPNOEA EXERTIONAL 1 0.0000
176 SEIZURE 3 0.0000
177 DEVICE BREAKAGE 1 0.0000
178 DEVICE DISLOCATION 1 0.0000
179 THROAT IRRITATION 1 0.0000
180 VISION BLURRED 3 0.0000
181 TINNITUS 1 0.0000
182 DYSPNOEA 12 0.0000
183 ANXIETY 6 0.0000
184 SYNCOPE 2 0.0000
185 CONDITION AGGRAVATED 6 0.0000
186 SINUSITIS 2 0.0000
187 HAEMOGLOBIN DECREASED 2 0.0000
188 NERVOUSNESS 1 0.0000
189 BRADYCARDIA 1 0.0000
190 EYE IRRITATION 1 0.0000
191 DYSPHONIA 1 0.0000
192 DISCOMFORT 1 0.0000
193 VISUAL IMPAIRMENT 2 0.0000
194 LOSS OF CONSCIOUSNESS 2 0.0000
195 BLOOD CREATININE INCREASED 1 0.0000
196 INFUSION RELATED REACTION 1 0.0000
197 PRODUCT QUALITY ISSUE 2 0.0000
198 DIZZINESS 7 0.0000
199 THERAPY INTERRUPTED 1 0.0000
200 DRUG INEFFECTIVE 18 0.0000
201 EPISTAXIS 1 0.0000
202 PARAESTHESIA 2 0.0000
203 THROMBOSIS 1 0.0000
204 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
205 INFLUENZA LIKE ILLNESS 1 0.0000
206 MYALGIA 2 0.0000
207 TACHYCARDIA 1 0.0000
208 OROPHARYNGEAL PAIN 1 0.0000
209 HYPERSENSITIVITY 2 0.0000
210 WEIGHT DECREASED 3 0.0000
211 BREAST CANCER 1 0.0000
212 CARDIAC DISORDER 1 0.0000
213 SWELLING 1 0.0000
214 DYSPHAGIA 1 0.0000
215 GAIT DISTURBANCE 2 0.0000
216 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
217 ABDOMINAL DISTENSION 1 0.0000
218 THROMBOCYTOPENIA 1 0.0000
219 RHEUMATOID ARTHRITIS 1 0.0000
220 PALPITATIONS 1 0.0000
221 EMOTIONAL DISTRESS 1 0.0000
222 HYPERHIDROSIS 1 0.0000
223 DRY SKIN 1 0.0000
224 PAIN IN EXTREMITY 2 0.0000
225 HYPOAESTHESIA 1 0.0000
226 BLOOD PRESSURE INCREASED 1 0.0000
227 PERIPHERAL SWELLING 1 0.0000
228 DRUG INTERACTION 1 0.0000
229 CONFUSIONAL STATE 1 0.0000
230 PYREXIA 2 0.0000
231 COVID-19 1 0.0000
232 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
233 NO ADVERSE EVENT 1 0.0000
234 PRODUCT USE ISSUE 1 0.0000
235 BLOOD GLUCOSE INCREASED 1 0.0000
236 FATIGUE 4 0.0000
237 HYPOTENSION 1 0.0000
238 SOMNOLENCE 1 0.0000
239 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
240 PAIN 3 0.0000
241 ARTHRALGIA 2 0.0000
242 MALAISE 2 0.0000
243 DECREASED APPETITE 1 0.0000
244 BACK PAIN 1 0.0000
245 INSOMNIA 1 0.0000
246 COUGH 1 0.0000
247 HEADACHE 2 0.0000
248 FALL 1 0.0000
249 PRURITUS 1 0.0000
250 DEATH 2 0.0000
251 DIARRHOEA 1 0.0000
252 NAUSEA 1 0.0000